Roohi Mariam Peter

In this article, we take a look at six biotech companies focused on bringing drugs to treat obesity to the market.

The therapeutic field of long non-coding (lnc) RNAs has flown under the radar for quite some time now since they emerged as targets belonging to the dark genome to treat various diseases.

Famously known as the powerhouse of the cell, the mitochondria is responsible for generating most of the energy that fuels cellular reactions.

Menopause marks the end of periods and fertility and is regarded as a natural part of aging.

Italian startup Aptadir has launched with $1.6M to develop drugs targeting DNA hypermethylation for cancer and genetic disorders.

Discover six innovative clinical-stage biotech companies fostering R&D in the Duchenne muscular dystrophy therapeutic space.

The biopharma industry is always in need of talented minds to take promising pipelines to the clinic and beyond.

We reached out to VCs to nominate prominent founders in the industry who are committed to bringing potentially life-changing treatments to market.

Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.

G protein-coupled receptors (GPCRs) are the largest and most diverse group of membrane receptors in the body.